Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
The University of Hong Kong
Changhai Hospital
M.D. Anderson Cancer Center
University of Chicago
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
National Institutes of Health Clinical Center (CC)
Institute of Oncology Ljubljana
National Institutes of Health Clinical Center (CC)
Stanford University
Chung Shan Medical University
British Columbia Cancer Agency
Montefiore Medical Center
National Institutes of Health Clinical Center (CC)
University of Wisconsin, Madison
University of Wisconsin, Madison
Guardant Health, Inc.